Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 159503-91-0 | MDL No. : | MFCD13181893 |
Formula : | C10H16BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PQILACDFDBWRNK-UHFFFAOYSA-N |
M.W : | 262.14 | Pubchem ID : | 44239841 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.7 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 63.99 |
TPSA : | 29.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.33 cm/s |
Log Po/w (iLOGP) : | 3.01 |
Log Po/w (XLOGP3) : | 2.21 |
Log Po/w (WLOGP) : | 2.53 |
Log Po/w (MLOGP) : | 2.04 |
Log Po/w (SILICOS-IT) : | 1.7 |
Consensus Log Po/w : | 2.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.574 mg/ml ; 0.00219 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.46 |
Solubility : | 0.899 mg/ml ; 0.00343 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.11 |
Solubility : | 2.03 mg/ml ; 0.00776 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With triphenyl phosphite; bromine; triethylamine In dichloromethane at -25 - -20℃; | 1st step: in the reaction bottle, will N-Boc-4-piperidone (19.9g, 0 . 1mol), triphenyl phosphite (34.1g, 0 . 11mol) and triethylamine (15.2g, 0 . 15mol) dissolved in 160 ml of methylene chloride, temperature control -25 ° C to -20 °C, instillment bromide (17.6g, 0 . 11mol) in dichloromethane (30 ml) solution, completion of the dropping, the stirring reaction heat. TLC detection after the reaction, the solvent is distilled under reduced pressure, subsequently joined 300mL95percent cold ethanol after stirring, the solid is filtered, the filtrate to dryness, by adding 150 ml of toluene and 40 ml moisture content level, toluene layer saturated salt water washing, solvent to obtain organic solvent turns on lathe does N-Boc-1, 2, 5, 6-tetrahydro-pyridine-4-bromo, internal standard calibration the yield is 80percent; |
72% | With triphenyl phosphite; triethylamine In dichloromethane at -25 - -15℃; | 1st step: in the reaction bottle, will N-Boc-4-piperidone (19.9g, 0 . 1mol), triphenyl phosphite (34.1g, 0 . 11mol) and triethylamine (15.2g, 0 . 15mol) dissolved in 160 ml of methylene chloride, temperature control -25 ° C to -15 °C, slow instillment bromide (19.2g, 0 . 12mol) in dichloromethane (30 ml) solution, completion of the dropping, the stirring reaction heat. TLC detection after the reaction, the solvent is distilled under reduced pressure, subsequently joined 330mL95percent cold ethanol after stirring, the solid is filtered, the filtrate to dryness, by adding 45 ml after sulfolane, vacuum distillation to obtain 18.9g colorless liquid N-Boc-1, 2, 5, 6-tetrahydro-pyridine-4-bromo, yield 72percent; |
[ 1035235-27-8 ]
tert-Butyl 4-bromoisoindoline-2-carboxylate
Similarity: 0.81
[ 893566-75-1 ]
Tert-butyl 8-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.80
[ 201940-08-1 ]
tert-Butyl 5-bromoisoindoline-2-carboxylate
Similarity: 0.78
[ 893566-74-0 ]
tert-Butyl 6-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.77
[ 258515-65-0 ]
tert-Butyl 7-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.77
[ 85838-94-4 ]
tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.84
[ 1035235-27-8 ]
tert-Butyl 4-bromoisoindoline-2-carboxylate
Similarity: 0.81
[ 893566-75-1 ]
Tert-butyl 8-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.80
[ 201940-08-1 ]
tert-Butyl 5-bromoisoindoline-2-carboxylate
Similarity: 0.78
[ 128372-89-4 ]
tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.78
[ 85838-94-4 ]
tert-Butyl 5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.84
[ 128372-89-4 ]
tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.78
[ 86447-11-2 ]
1-Boc-1,2,5,6-tetrahydropyridine-3-carboxylic acid
Similarity: 0.71
[ 873551-20-3 ]
tert-Butyl 4-cyano-5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.71
[ 66207-23-6 ]
Benzyl 5,6-dihydropyridine-1(2H)-carboxylate
Similarity: 0.70